Palisade Bio (PALI) FCF Margin Growth (1y) (2012 - 2020)
Powered by 
Analysis
Palisade Bio (PALI) FCF Margin Growth (1y) (2012 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 811.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19,111.00 |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 2.00 Mn |
| Sep 30, 2020 | 4.12 Mn |
| Jun 30, 2020 | -639,744.00 |
| Mar 31, 2020 | 3.80 Mn |
| Dec 31, 2019 | -1.57 Mn |
| Sep 30, 2019 | -933,128.00 |
| Jun 30, 2019 | -1.95 Mn |
| Mar 31, 2019 | 816,676.00 |
| Dec 31, 2018 | -6.53 Mn |
| Sep 30, 2018 | 6.64 Mn |
| Jun 30, 2018 | 13.42 Mn |
| Mar 31, 2018 | 10.34 Mn |
| Dec 31, 2017 | 4.57 Mn |
| Sep 30, 2017 | 4.61 Mn |
| Jun 30, 2017 | 1.10 Mn |
| Mar 31, 2017 | -3.73 Mn |
| Dec 31, 2016 | 11.12 Mn |
| Sep 30, 2016 | 4.26 Mn |
| Jun 30, 2016 | 4.92 Mn |
| Mar 31, 2016 | 2.22 Mn |